Suboxone cost per signed retainer
Suboxone (tooth decay and dental injury) carries a cost per signed retainer of $1,800–$2,600 in Q1 2026, current as of March 31, 2026, at an 11–16% signed rate and a medium qualification tier. Litigation status (verified November 17, 2026): active federal mdl. Sample size and confidence interval for this row are not available; the reason is stated on each figure below rather than omitted.
Data as of Updated Q1 2026 releaseLatest published release; the next quarterly release has not been published yet
Suboxone litigation status & sources
Active federal MDLStatus verified on against primary sources · next check due
As of Nov 2026, Suboxone film dental-injury claims are centralized in MDL 3092 (N.D. Ohio, Judge J. Philip Calabrese), which had 2,016 pending actions per the JPML's Nov. 2, 2026 report. The case is in bellwether core discovery and no trial date was confirmed.
- Proceeding
- MDL 3092 (N.D. Ohio)
- Judge J. Philip Calabrese
- Pending actions
- 2,016
- JPML Pending MDL Dockets by District, report date 11/2/2026
Key dates
- The court entered the Second Amended Case Management Order No. 15 (Bellwether Protocol) on March 27, 2026.
- The court entered Case Management Order No. 23 on provider depositions in the Core Discovery Pool on July 16, 2026.
Sources
- JPMLJPML Pending MDL Dockets by District (Nov. 2, 2026)
- CourtN.D. Ohio: MDL 3092 Suboxone Film Products Liability Litigation
Marketing information for law firms, not legal advice. Litigation status changes; confirm filing posture, case criteria and deadlines with counsel before launching or continuing a campaign. How we source and date this: editorial standards.
CPR range · Q1 2026
$1,800 – $2,600
Median: n/a — Per-tort medians are not published. The dataset carries the interquartile low and high bounds for each tort; only the national median is published as a point value.
Signed rate
11–16%
Share of exclusive leads that become signed retainers.
Qualification tier
Medium
Relative difficulty of clearing this tort's qualifying criteria.
Litigation status
Active federal MDL
Verified November 17, 2026 against primary sources.
Sample size
n/a
Per-tort sample sizes are not broken out in the published dataset. The panel total (140 firms, $180M of annual mass tort lead spend across 16 active tort categories) is published at the panel level only, so the number of firms and the spend basis behind any single row cannot be stated.
Confidence interval
n/a
Not computable from the published dataset. Benchmarks are published as trimmed interquartile ranges, and the per-observation values a confidence interval requires are not retained in the published figures.
Unverified
No third party has reviewed this methodology or the underlying data. Mass Tort Marketing Agency sells the leads these figures price.
What third-party verification would involveSuboxone CPR over time
The series for Suboxone starts at Q1 2026. Mass Tort Marketing Agency holds one published quarter of per-tort data for this tort, so there is no trend line to draw yet — the single point is shown below, and a second point will appear when the next quarter publishes.
| Quarter | CPR low | CPR high | Note |
|---|---|---|---|
| Q4 2024 | n/a | n/a | No per-tort breakdown for Q4 2024 is held in the dataset. Only the national median is held for that quarter, which is why the per-tort trend series begins at Q1 2026. |
| Q1 2026 | $1,800 | $2,600 | Published. |
What qualifies a Suboxone claimant
Documented Suboxone sublingual film use for a minimum duration, plus specific dental injuries including tooth loss, severe caries, or documented root-canal necessity.
Falloff: n/a — Not published for this tort. The source dataset describes Suboxone falloff risk qualitatively (doubled by the dual medical and dental documentation requirement) without a numeric range.
Active — what that means for acquisition
Active mid-range tort. Qualification difficulty is moderate and the claimant pool overlaps with opioid-recovery demographics, which requires more careful outreach. Firms succeeding here build referral relationships with dental practitioners in Medicaid-dense markets to complement paid acquisition. Pure paid-digital campaigns run at the upper end of the range because qualification requires both medical and dental documentation, doubling falloff risk; dental-dominant intake workflows can compress CPR 15-20% below pure paid-digital economics.
Suboxone cost per lead
This dataset does not publish a cost-per-lead figure for Suboxone, and no CPL value is shown here rather than being derived from the CPR band. The two are related by the signed rate — CPL is approximately CPR × signed rate — but running that multiplication against a published interquartile band produces a number that looks measured and is not, so it is left out. What the benchmark does state is the signed rate: 11–16% of exclusive Suboxone leads become signed retainers that survive the 30-day falloff window. If you have your own CPL from a vendor quote, that signed rate is the multiplier that turns it into a comparable CPR.
Download this row
How to cite this page
Suggested citation:
Mass Tort Marketing Agency. "Suboxone (tooth decay and dental injury) cost per signed retainer." Q1 2026 CPR Benchmark, published April 24, 2026. https://www.masstortmarketingagency.com/benchmarks/suboxone
- Canonical URL:
- https://www.masstortmarketingagency.com/benchmarks/suboxone
- License:
- CC BY 4.0 — reuse permitted with attribution to Mass Tort Marketing Agency CPR Benchmark, https://www.masstortmarketingagency.com/benchmarks/
Citing a number that must stay stable? Point at a dated snapshot instead of the live page — snapshot files never change.
